Overview

Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia

Status:
Unknown status
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
Use Huperzine-A, a herbal supplement normally used for treatment of Alzheimer's disease, to potentially improve cognitive dysfunction (memory problems) and functional capacity (ability to perform common daily tasks such as cooking, bathing, telephone, shopping) in people with schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
VA Nebraska Western Iowa Health Care System
Collaborator:
American Legion of Iowa Foundation
Treatments:
Huperzine A